RT Journal Article
SR Electronic
T1 Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.20.22272651
DO 10.1101/2022.03.20.22272651
A1 Szewczyk-Dąbrowska, Alina
A1 Budziar, Wiktoria
A1 Baniecki, Krzysztof
A1 Pikies, Aleksandra
A1 Harhala, Marek
A1 Jędruchniewicz, Natalia
A1 Kaźmierczak, Zuzanna
A1 Gembara, Katarzyna
A1 Klimek, Tomasz
A1 Witkiewicz, Wojciech
A1 Nahorecki, Artur
A1 Barczyk, Kamil
A1 Grata-Borkowska, Urszula
A1 Dąbrowska, Krystyna
YR 2022
UL http://medrxiv.org/content/early/2022/03/23/2022.03.20.22272651.abstract
AB The immune response and specific antibody production in COVID-19 are among the key factors that determine both prognostics for individual patients and the global perspective for controlling the pandemics. So called “dark figure”, that is, a part of population that has been infected but not registered by the health care system, make it difficult to estimate herd immunity and to predict pandemic trajectories.Here we present a follow up study of population screening for hidden herd immunity to SARS-CoV-2 in individuals who had never been positively diagnosed against SARS-CoV-2; the first screening was in May 2021, and the follow up in December 2021. We found that specific antibodies targeting SARS-CoV-2 detected in May as the “dark figure” cannot be considered important 7 months later due to their significant drop. On the other hand, among participants who at the first screening were negative for anti-SARS-CoV-2 IgG, and who have never been diagnosed for SARS-CoV-2 infection nor vaccinated, 26% were found positive for anti-SARS-CoV-2 IgG. This can be attributed to of the “dark figure” of the recent, fourth wave of the pandemic that occurred in Poland shortly before the study in December. Participants who were vaccinated between May and December demonstrated however higher levels of antibodies, than those who undergone mild or asymptomatic (thus unregistered) infection. Only 7% of these vaccinated participants demonstrated antibodies that resulted from infection (anti-NCP). The highest levels of protection were observed in the group that had been infected with SARS-CoV-2 before May 2021 and also fully vaccinated between May and December.These observations demonstrate that the hidden fraction of herd immunity is considerable, however its potential to suppress the pandemics is limited, highlighting the key role of vaccinations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by The National Centre for Research and Development in Poland, grant no. SZPITALEJEDNOIMIENNE/48/2020.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Bioethical Commission of the Regional Specialist Hospital in Wroclaw (approval number: KB/02/2020, policy No. COR193657) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors